Data / Research funding / HPV and/or Cervical Cancer Vaccines

HPV and/or Cervical Cancer Vaccines: 95 NIH awards ($194.5M) to 65 organizations

Name: NIH and NSF awards on HPV and/or Cervical Cancer Vaccines
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

95 NIH awards ($194.5M) in the NIH spending category HPV and/or Cervical Cancer Vaccines, to 65 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.

SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.

Get awards on HPV and/or Cervical Cancer Vaccines Watch HPV and/or Cervical Cancer Vaccines

Topic: NIH spending category

Awards

95 awards in the window.

Award	Agency	Institute or division	Fiscal year	Amount in window	Start	End	Principal investigator	Source
Cancer Center Support Grant (CCSG)	NIH	National Cancer Institute	2021 to 2025	$35,080,297	April 1, 1997	February 28, 2026	ROBERTS, CHARLES	reporter.nih.gov
FOLLOW-UP AND EXTENDED FOLLOW-UP OF PARTICIPANTS	NIH	National Cancer Institute	2021 to 2025	$29,487,084	April 6, 2018	September 15, 2026	PORRAS, CAROLINA	reporter.nih.gov
Cancer Center Support Grant P30	NIH	National Cancer Institute	2021 to 2025	$17,994,069	July 1, 2002	June 30, 2026	LARA, PRIMO N.	reporter.nih.gov
University of Arizona Cancer Prevention Clinical Trials Network	NIH	National Cancer Institute	2021 to 2025	$7,572,043	August 16, 2019	July 31, 2031	THOMPSON, PATRICIA ANN	reporter.nih.gov
California-Mexico-Puerto Rico Partnership (CAMPO) Center for Prevention of HPV-related Cancer in HIV+ Populations	NIH	National Cancer Institute	2021 to 2025	$6,605,241	September 12, 2019	July 31, 2026	PALEFSKY, JOEL MICHAEL	reporter.nih.gov
Comparative Modeling to Inform Cervical Cancer Control Policies	NIH	National Cancer Institute	2021 to 2024	$6,568,988	September 8, 2020	August 31, 2025	KIM, JANE JOOYUN	reporter.nih.gov
Partnership for Prevention of HPV-Associated Cancers in People Living with HIV: Brazil, Mexico, and Puerto Rico	NIH	National Cancer Institute	2021 to 2025	$5,948,066	September 20, 2019	July 31, 2026	ELLSWORTH, GRANT B.	reporter.nih.gov
Cervical, Anal & Oral HPV Persistence/Adolescent Girls	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2025	$5,549,203	May 15, 2007	January 31, 2028	DIAZ, ANGELA	reporter.nih.gov
Understanding and Enhancing T-Cell Responses to High Risk Human Papillomaviruses-Renewal	NIH	National Cancer Institute	2021 to 2025	$3,585,446	July 1, 2010	June 30, 2027	NAKAGAWA, MAYUMI	reporter.nih.gov
EXTENSION OF ESCUDDO FOLLOW-UP FROM FIVE YEARS TO 7.5 YEARS (REFERRED TO AS ESCUDDO-7)	NIH	National Cancer Institute	2025	$3,083,060	March 26, 2025	September 15, 2025		reporter.nih.gov
Supporting Informed Parental Decisions on HPV Vaccination through Safe and Personalized AI-Driven Conversations	NIH	National Cancer Institute	2025	$2,834,092	August 15, 2025	July 31, 2029	NAN, XIAOLI	reporter.nih.gov
Implementation of evidence-based strategies to optimize HPV vaccination in rural primary care settings	NIH	National Institute on Minority Health and Health Disparities	2022 to 2025	$2,685,848	August 21, 2022	April 30, 2027	RODRIGUEZ, ELISA MARIE	reporter.nih.gov
The HPV9-10 Trial: Early Initiation of HPV Vaccination	NIH	National Cancer Institute	2021 to 2024	$2,537,601	May 1, 2020	April 30, 2026	KEMPE, ALLISON	reporter.nih.gov
Human Papillomavirus and Polyomavirus Associated Malignancies.	NIH	National Cancer Institute	2021 to 2023	$2,515,952	September 15, 2017	August 31, 2024	GALLOWAY, DENISE A.	reporter.nih.gov
TweenVax: A comprehensive practice-, provider-, and parent/patient-level intervention to improve adolescent HPV vaccination.	NIH	National Cancer Institute	2021 to 2025	$2,505,141	July 1, 2024	June 30, 2027	BEDNARCZYK, ROBERT A.	reporter.nih.gov
Real-world effectiveness of HPV vaccine in women living with HIV and its impact on cervical cancer screening accuracies	NIH	National Cancer Institute	2023 to 2025	$2,109,984	May 1, 2023	April 30, 2029	MOSCICKI, ANNA-BARBARA	reporter.nih.gov
PCOM2 - The Physician Communication Intervention, Version 2.0	NIH	National Cancer Institute	2022 to 2025	$2,078,331	January 15, 2022	December 31, 2026	O'LEARY, SEAN T	reporter.nih.gov
Conversational Agents to Improve HPV Vaccine Acceptance in Primary Care	NIH	National Cancer Institute	2022 to 2024	$2,002,128	September 1, 2022	April 1, 2025	PAASCHE-ORLOW, MICHAEL	reporter.nih.gov
Advancing the implementation of evidence-based strategies for HPV vaccination in safety-net primary care settings	NIH	National Cancer Institute	2021 to 2025	$1,912,883	August 20, 2020	April 30, 2027	TSUI, JENNIFER	reporter.nih.gov
PREVENT - Practice-based Approaches to Promote HPV Vaccination	NIH	National Cancer Institute	2023 to 2025	$1,908,049	May 15, 2023	April 30, 2028	KEPKA, DEANNA LEE	reporter.nih.gov
An inoculation theory-based messaging intervention addressing misinformation about HPV vaccine on social media: The Inoculate for HPV Vaccine randomized controlled trial	NIH	National Cancer Institute	2022 to 2025	$1,903,422	April 12, 2022	April 2, 2025	KORNIDES, MELANIE LYNN	reporter.nih.gov
The STOP-HPV Scale-Up Study	NIH	National Cancer Institute	2023 to 2025	$1,836,530	April 1, 2023	March 31, 2028	SZILAGYI, PETER G	reporter.nih.gov
Mouse modeling of HPV infection	NIH	National Cancer Institute	2021 to 2023	$1,759,688	December 1, 2018	November 30, 2024	HUNG, CHIEN-FU	reporter.nih.gov
Development of Novel Spontaneous HPV Cervicovaginal Carcinoma Models for Cancer Immunotherapy	NIH	National Cancer Institute	2021 to 2023	$1,725,233	April 1, 2019	March 31, 2024	WU, TZYY-CHOOU	reporter.nih.gov
High-risk HPV E6: dysregulation of immortalization, growth, and differentiation through protein partnerships in HPV-associated cancers	NIH	National Cancer Institute	2021 to 2024	$1,677,482	June 4, 2014	May 31, 2026	KATZENELLENBOGEN, RACHEL ADRIA	reporter.nih.gov
Effectiveness of the HPV Vaccine in Immunocompromised Populations	NIH	National Institute of Allergy and Infectious Diseases	2024 to 2025	$1,654,519	July 9, 2024	May 31, 2029	SILVERBERG, MICHAEL J	reporter.nih.gov
HPV ECHO: Increasing the adoption of evidence-based communication strategies for HPV vaccination in rural primary care practices	NIH	National Cancer Institute	2021 to 2024	$1,617,347	August 10, 2020	April 1, 2025	CALO, WILLIAM ALEXIS	reporter.nih.gov
RCT to Evaluate an Implementation Strategy to Increase Optimal Use of HPV Vaccine in Primary Care	NIH	National Cancer Institute	2021 to 2024	$1,587,810	July 2, 2019	June 30, 2025	KING, ALLISON A	reporter.nih.gov
Multilevel Peer-to-Peer HPV Vaccination and Wellness Educational Program in School Based Health Centers (PEER)	NIH	National Institute on Minority Health and Health Disparities	2024 to 2025	$1,559,037	August 28, 2024	March 31, 2029	PETRIK, AMANDA F.	reporter.nih.gov
A Randomized Controlled Trial of an HPV Vaccine Intervention for Young Sexual Minority Men	NIH	National Cancer Institute	2021 to 2023	$1,471,557	April 1, 2018	March 21, 2025	REITER, PAUL L	reporter.nih.gov
Actions for Collaborative Community Engaged Strategies for HPV (ACCESS-HPV)	NIH	National Cancer Institute	2023 to 2025	$1,457,658	September 22, 2022	August 31, 2027	IWELUNMOR, JULIET	reporter.nih.gov
Utilization of cervical cancer prevention tools and role of high-risk HPV type in the persistent cervical cancer disparities experienced by American Indian/Alaska Native women	NIH	National Cancer Institute	2021 to 2025	$1,257,642	August 1, 2021	July 31, 2026	BRUEGL, AMANDA S	reporter.nih.gov
Epidemiologic Impact of HPV Vaccination	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$1,253,203	January 18, 2013	July 31, 2025	DING, LILI	reporter.nih.gov
Implementation of a Provider-Focused Intervention for Maximizing HPV Vaccine Uptake in Young Cancer Survivors receiving Follow-Up Care in Pediatric Oncology Practices: A Cluster-Randomized Trial	NIH	National Cancer Institute	2023 to 2024	$1,158,790	September 18, 2020	August 31, 2025	LANDIER, WENDY	reporter.nih.gov
"Less Pain, Less Fuss, Right Now!" and "Make It Count!"- Multilevel Interventions for Patient, Parent, and Practice to Enhance Provider Recommendations for HPV Vaccination	NIH	National Cancer Institute	2022 to 2023	$1,143,881	April 1, 2018	March 31, 2025	JACOBSON, ROBERT M.	reporter.nih.gov
Sample-to-answer HPV DNA nucleic acid test for cervical cancer screening in Mozambique	NIH	National Cancer Institute	2024 to 2025	$1,129,641	September 1, 2024	August 31, 2029	RICHARDS-KORTUM, REBECCA R.	reporter.nih.gov
Implementation of School-Entry Policies for Human Papillomavirus Vaccination	NIH	National Cancer Institute	2021 to 2023	$1,111,147	December 1, 2018	November 30, 2025	COLON, VIVIAN	reporter.nih.gov
Cervical Cancer Prevention Prebiotic Device	NIH	National Cancer Institute	2025	$1,039,382	June 17, 2021	August 31, 2027	ELLINGTON, JOANNA ELIZABETH	reporter.nih.gov
Improving HPV Vaccination Delivery in Pediatric Primary Care: The STOP-HPV Trial	NIH	National Cancer Institute	2021 to 2022	$991,895	February 3, 2017	January 31, 2024	SZILAGYI, PETER G	reporter.nih.gov
Rwanda CASCADE Clinical Trials Site for cervical cancer prevention	NIH	National Cancer Institute	2023 to 2025	$928,400	September 22, 2023	May 31, 2027	RUBAGUMYA, FIDEL	reporter.nih.gov
Early Oropharyngeal cancer and screening in Gay and Bisexual Men	NIH	National Cancer Institute	2021 to 2022	$894,702	September 1, 2020	March 19, 2025	ROSS, MICHAEL W	reporter.nih.gov
THE CONTRACTOR SHALL MAINTAIN AND SUPPORT STUDY DATA INFRASTRUCTURE, DATA MANAGEMENT AND DATA PREPARATION, AND ADVANCED STATISTICAL AND BIOINFORMATICS	NIH	National Cancer Institute	2021 to 2024	$887,000	September 23, 2022	August 15, 2025	GIFFEN, CAROL	reporter.nih.gov
Framing HPV Vaccination Messages for African American Parents	NIH	National Cancer Institute	2021 to 2022	$879,776	February 13, 2018	January 31, 2025	NAN, XIAOLI	reporter.nih.gov
Translational Use of Intradermal Needle-free Injector to facilitate and optimize global fractional dose HPV vaccine administration	NIH	National Cancer Institute	2022 to 2023	$843,564	September 20, 2022	May 17, 2024	NATHALIE, LANDRY	reporter.nih.gov
Hashtag HPV: Engaging parents through social media to increase HPV vaccination	NIH	National Cancer Institute	2021 to 2022	$814,792	September 15, 2021	August 31, 2024	LO, WEN-JUO	reporter.nih.gov
Therapeutic use of HPV L1 Vaccine in Anogenital Neoplasia: VIVA Trial	NIH	National Cancer Institute	2022	$780,737	February 22, 2017	January 31, 2024	MADELEINE, MARGARET M	reporter.nih.gov
SEARCH: SMS Electronic Adolescent Reminders for Completion of HPV vaccination- Uganda	NIH	National Cancer Institute	2023 to 2025	$775,284	August 1, 2020	July 31, 2027	STOCKWELL, MELISSA S	reporter.nih.gov
Investigating Behavioral Mechanisms and Efficacy of a Provider-Directed Intervention for HPV Vaccine Promotion in Real-World Dental Settings	NIH	National Institute of Dental & Craniofacial Research	2025	$757,577	February 1, 2023	March 10, 2025	RINDAL, D. BRAD	reporter.nih.gov
Development of Systems and Education for Cervical Cancer prevention (DOSE-CC)	NIH	National Cancer Institute	2025	$753,446	May 1, 2025	April 30, 2030	LUNZE, KARSTEN	reporter.nih.gov
Investigating Behavioral Mechanisms and Efficacy of a Provider-Directed Intervention for HPV Vaccine Promotion in Real-World Dental Settings	NIH	National Institute of Dental & Craniofacial Research	2023 to 2024	$732,776	February 1, 2023	February 28, 2025	RINDAL, D. BRAD	reporter.nih.gov
Investigation of Oral HPV Infection Natural History and Biomarkers of Persistent Infection: The HIM Study	NIH	National Cancer Institute	2021	$711,793	March 21, 2017	February 29, 2024	GIULIANO, ANNA R.	reporter.nih.gov
Addressing HPV vaccination disparities through tailored messaging for hesitant families	NIH	National Cancer Institute	2022 to 2024	$659,697	August 2, 2022	April 1, 2025	KOHLER, RACQUEL ELIZABETH	reporter.nih.gov
Strategies to Reduce Global Health Disparities in Cervical Cancer	NIH	National Cancer Institute	2025	$630,506	January 1, 2025	December 31, 2029	WU, TZYY-CHOOU	reporter.nih.gov
Actions for Collaborative Community Engaged Strategies for HPV (ACCESS HPV)	NIH	National Cancer Institute	2022 to 2023	$566,887	September 22, 2022	September 2, 2023	IWELUNMOR, JULIET	reporter.nih.gov
Human Papillomavirus and Polyomavirus Associated Malignancies.	NIH	National Cancer Institute	2021	$521,176	September 15, 2017	March 31, 2022	GALLOWAY, DENISE A.	reporter.nih.gov
University of California, Davis: Human Papillomavirus Cancer Free (UCD: HPV Cancer Free)	NIH	National Cancer Institute	2023 to 2025	$503,820	September 1, 2023	August 31, 2028	DANG, JULIE	reporter.nih.gov
Let’s K-Talk: A Storytelling Intervention Leveraging Chatbot Technology to Prevent HPV and HPV Associated Cancers for Ethnic Koreans Living in the U.S.	NIH	National Institute of Nursing Research	2022 to 2024	$489,666	September 23, 2022	July 31, 2025	KIM, MINJIN	reporter.nih.gov
Low cost, Broad Spectrum Cancer Vaccine Targeting Human Papillomavirus	NIH	National Cancer Institute	2022	$437,203	July 1, 2022	March 31, 2025	PARDHE, MARY	reporter.nih.gov
Development and user testing of a culturally targeted anal cancer prevention decision tool	NIH	National Institute on Minority Health and Health Disparities	2023 to 2024	$435,875	May 16, 2023	December 31, 2025	WHELDON, CHRISTOPHER W.	reporter.nih.gov
A co-infection model for papillomavirus associated infections and cancers	NIH	National Cancer Institute	2023 to 2024	$432,985	April 1, 2023	March 31, 2026	HU, JIAFEN	reporter.nih.gov
Role of antigen valency and pattern recognition receptor ligands in HPV vaccine-induced durable B cell memory	NIH	National Institute of Allergy and Infectious Diseases	2022 to 2023	$430,375	June 1, 2022	May 31, 2025	SCHERER, ERIN M	reporter.nih.gov
Increasing HPV vaccine uptake in community-based pediatric practices	NIH	National Cancer Institute	2021	$427,380	December 20, 2016	November 30, 2023	HULL, PAMELA CARMEN	reporter.nih.gov
From Academia to Business: Development of Novel Therapeutics Against HPV-Associated Cancer	NIH	National Cancer Institute	2022	$420,989	March 1, 2022	April 30, 2023	RIETZ, ANNE	reporter.nih.gov
Toward Racial Equity and Justice in Human Papillomavirus (HPV) Vaccination: An Exploratory Study with Cape Verdean Parents	NIH	National Institute on Minority Health and Health Disparities	2023 to 2024	$419,375	July 15, 2023	January 31, 2026	LINDSAY, ANA CRISTINA TERRA DE SOUZA	reporter.nih.gov
Immunomodulatory effects of topical artesunate on cervical intraepithelial neoplasia 2/3.	NIH	National Cancer Institute	2022 to 2023	$417,215	March 1, 2022	December 28, 2024	TRIMBLE, CORNELIA L	reporter.nih.gov
Pilot Testing of a Game-Based Intervention to Promote HPV Vaccination in Families with Unvaccinated Children	NIH	National Institute of Nursing Research	2023 to 2024	$401,343	August 16, 2023	July 31, 2025	CHEN, ANGELA CHIA-CHEN	reporter.nih.gov
The role of bacterial vaginosis-associated bacteria in papillomavirus persistence and cancers	NIH	National Cancer Institute	2022 to 2023	$393,218	March 1, 2022	February 28, 2025	HU, JIAFEN	reporter.nih.gov
HPV POINT OF CARE MOLECULAR DIAGNOSTICS FOR LMICS	NIH	National Cancer Institute	2022	$382,034	September 16, 2022	September 15, 2023	MOUNZIH, KHALID	reporter.nih.gov
Investigating facilitator-driven, multi-level implementation strategies in Federally Qualified Health Centers to improve provider recommendation and HPV vaccination rates among Latino/a adolescents	NIH	National Cancer Institute	2023	$351,394	September 1, 2023	May 31, 2024	MORALES-CAMPOS, DAISY YVETTE	reporter.nih.gov
Harnessing Big Data to Identify Geographic Clusters of Low-income children with Poor HPV Vaccination Rates	NIH	National Institute on Minority Health and Health Disparities	2022 to 2024	$343,172	September 1, 2021	May 31, 2025	SONAWANE, KALYANI	reporter.nih.gov
People living with HIV (PLWH), Oral and Oropharyngeal Cancer, and Health Equity: A Qualitative Study	NIH	National Institute of Dental & Craniofacial Research	2023 to 2024	$323,788	July 10, 2023	June 30, 2025	HERNANDEZ, ALEXANDRA LYDIA	reporter.nih.gov
A tailored, health communication intervention for HPV vaccine hesitant families	NIH	National Cancer Institute	2021 to 2023	$311,679	June 1, 2020	October 31, 2023	ERVES, JENNIFER C.	reporter.nih.gov
Small Molecule E6 Inhibitors to Treat Dysplasia Caused by HPV Infections	NIH	National Institute of Allergy and Infectious Diseases	2022	$298,527	July 1, 2022	March 31, 2024	LU, ZHIJIAN	reporter.nih.gov
Characterizing parental beliefs to support optimization of vaccine introduction	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2023	$277,617	December 1, 2018	November 30, 2023	WAGNER, ABRAM LUTHER	reporter.nih.gov
Small Molecule E6 Inhibitors to Treat Oropharyngeal Cancers Caused by HPV Infections	NIH	National Institute of Dental & Craniofacial Research	2022	$275,766	September 1, 2022	August 31, 2024	LU, ZHIJIAN	reporter.nih.gov
Stories to Prevent (StoP) HPV Cancers: A communication intervention to increase HPV vaccination among diverse populations	NIH	National Cancer Institute	2025	$233,411	April 1, 2025	March 31, 2027	CALO, WILLIAM ALEXIS	reporter.nih.gov
Albumin-FMS-like tyrosine kinase 3 ligand (Alb-Flt3L) fusion protein as a novel adjuvant to enhance the immunogenicity and therapeutic and prophylactic efficacies of a HPV protein vaccine	NIH	National Cancer Institute	2021	$229,659	March 1, 2020	February 28, 2023	HUNG, CHIEN-FU	reporter.nih.gov
Therapeutic use of HPV L1 Vaccine in Anogenital Neoplasia: VIVA Trial	NIH	National Cancer Institute	2021	$227,161	February 22, 2017	March 31, 2022	MADELEINE, MARGARET M	reporter.nih.gov
Increasing HPV Vaccination Rates through Virtual Immersive Communication Training on Recommending Immunizations: An Efficacy Study of VICTORI	NIH	National Cancer Institute	2021	$223,499	December 1, 2019	November 30, 2022	REAL, FRANCIS	reporter.nih.gov
Applying the Multiphase Optimization Strategy to Develop and Test a Culturally-Relevant Digital Health Intervention Targeting HPV Vaccination among U.S. Vietnamese	NIH	National Cancer Institute	2025	$191,700	January 15, 2025	December 31, 2029	VU, HA NGAN	reporter.nih.gov
Identifying False HPV-Vaccine Information and Modeling Its Impact on Risk Perceptions	NIH	National Cancer Institute	2021	$174,255	April 1, 2020	March 31, 2024	CHIN, JESSIE	reporter.nih.gov
HPV and HPV-related cancer prevention prevalence among people experiencing homelessness in the United States, 2006-2018	NIH	National Cancer Institute	2025	$170,409	August 1, 2025	July 31, 2027	GALVIN, ANNALYNN MAGUDDAYAO	reporter.nih.gov
Examining the Integrative Effects of Adolescent, Parent, Provider, and Practice Level Factors on Adolescents' HPV Vaccine Uptake across Six Asian American Subgroups	NIH	National Cancer Institute	2022 to 2023	$166,384	February 1, 2022	July 31, 2024	ZHU, LIN	reporter.nih.gov
Implementation of Inpatient Postpartum Human Papillomavirus Immunization	NIH	National Cancer Institute	2021	$165,013	July 11, 2018	June 30, 2023	SHETH, SANGINI S.	reporter.nih.gov
Identifying modifiable multi-level factors associated with HPV vaccine uptake in Kenya and Malawi	NIH	National Cancer Institute	2022	$163,500	September 19, 2022	August 31, 2023	MOUCHERAUD, CORRINA	reporter.nih.gov
The Role of Sex-Hormones in Anal Human Papilloma Virus Persistence (HPV) and Systemic and Mucosal Immunity in people with or at risk for HIV	NIH	National Institute of Allergy and Infectious Diseases	2025	$140,740	September 12, 2025	August 31, 2030	HARFOUCH, OMAR	reporter.nih.gov
A Novel Strategy to Identify Protective T cell Epitopes for HPV Therapeutic Vaccine	NIH	National Institute of Allergy and Infectious Diseases	2025	$131,166	August 1, 2025	July 31, 2027	GAO, FEI	reporter.nih.gov
Development of a nitric oxide-releasing antiviral gel for the treatment of cervical HPV infections and prevention of downstream malignancies in women	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2023	$126,371	February 1, 2019	February 28, 2024	RICCIO, DANIEL	reporter.nih.gov
Harnessing Big Data to Identify Geographic Clusters of Low-income children with Poor HPV Vaccination Rates	NIH	National Institute on Minority Health and Health Disparities	2021 to 2022	$120,922	September 1, 2021	August 8, 2022	SONAWANE, KALYANI	reporter.nih.gov
Evaluating the Influence of Culture and Risk Perception on HPV Vaccination Intention among Haitian Immigrant Women Living with HIV	NIH	National Institute of Nursing Research	2023 to 2024	$98,146	May 23, 2023	March 31, 2025	GUILLAUME, DOMINIQUE GISELE	reporter.nih.gov
Individual, Interpersonal, and Community Factors Associated with HPV Vaccine Hesitancy among Mexican American Young Adult Women	NIH	National Institute on Minority Health and Health Disparities	2021	$46,036	September 1, 2020	August 31, 2022	GARCIA, SAMANTHA	reporter.nih.gov
Implementation Penetration Assessment Criteria Tool for HPV Vaccination- Promoting Uptake among Young Girls in Nigeria	NIH	National Cancer Institute	2024	$36,801	February 5, 2025	February 4, 2027	ANIKAMADU, ONYEKACHUKWU	reporter.nih.gov
SUPPORT FOR HPV16L1/RG1 CHIMERIC VIRUS-LIKE PARTICLE VACCINE CLINICAL DEVELOPMENT TASKS 1&2	NIH	National Cancer Institute	2021	$28,823	September 25, 2015	March 31, 2021	LYUBIMOV, ALEXANDER	reporter.nih.gov
Hashtag HPV: Engaging parents through social media to increase HPV vaccination	NIH	National Cancer Institute	2021	$9,793	August 8, 2019	August 2, 2021	MASSEY, PHILIP M	reporter.nih.gov
Vietnamese-American parents' HPV vaccine uptake for their adolescent children: An examination of practice-, provider-, and patient-level influences	NIH	National Cancer Institute	2021	$4,938	July 22, 2019	August 31, 2021	VU, HA NGAN	reporter.nih.gov

Organizations

Organization	Place	NIH awards	NIH amount	NSF amount
ST. Jude Children's Research Hospital	Memphis, TN	1	$35.1 million	$0
Fundacion Inciensa	San Jose	2	$32.6 million	$0
University of California at Davis	Davis, CA	2	$18.5 million	$0
University of Arizona	Tucson, AZ	1	$7.6 million	$0
University of California, San Francisco	San Francisco, CA	2	$6.9 million	$0
Harvard University D/b/a Harvard School of Public Health	Boston, MA	1	$6.6 million	$0
Weill Medical Coll of Cornell Univ	New York, NY	1	$5.9 million	$0
Icahn School of Medicine at Mount Sinai	New York, NY	1	$5.5 million	$0
University of California Los Angeles	Los Angeles, CA	4	$5.1 million	$0
Johns Hopkins University	Baltimore, MD	6	$4.9 million	$0
University of Colorado Denver	Aurora, CO	2	$4.6 million	$0
University of Maryland, College Park	College Park, MD	2	$3.7 million	$0
Univ of Arkansas for Med Scis	Little Rock, AR	1	$3.6 million	$0
Fred Hutchinson Cancer Center	Seattle, WA	2	$3.3 million	$0
Kaiser Foundation Research Institute	Oakland, CA	2	$3.2 million	$0
Washington University	Saint Louis, MO	3	$3.1 million	$0
Emory University	Atlanta, GA	3	$2.9 million	$0
Roswell Park Cancer Institute Corp	Buffalo, NY	1	$2.7 million	$0
Pennsylvania State Univ Hershey Med CTR	Hershey, PA	4	$2.7 million	$0
Tufts Medical Center	Boston, MA	1	$2 million	$0
University of Southern California	Los Angeles, CA	1	$1.9 million	$0
University of Utah	Salt Lake City, UT	1	$1.9 million	$0
University of Pennsylvania	Philadelphia, PA	1	$1.9 million	$0
Indiana University Indianapolis	Indianapolis, IN	1	$1.7 million	$0
Healthpartners Institute	Bloomington, MN	2	$1.5 million	$0
Cincinnati Childrens Hosp Med CTR	Cincinnati, OH	2	$1.5 million	$0
Ohio State University	Columbus, OH	1	$1.5 million	$0
Oregon Health & Science University	Portland, OR	1	$1.3 million	$0
University of Alabama at Birmingham	Birmingham, AL	1	$1.2 million	$0
Mayo Clinic Rochester	Rochester, MN	1	$1.1 million	$0
William Marsh Rice University	Houston, TX	1	$1.1 million	$0
Comprehensive Cancer Center/ Univ/pr	San Juan, PR	1	$1.1 million	$0
Glyciome, LLC	Valleyford, WA	1	$1 million	$0
Kovina Therapeutics Inc.	Indianapolis, IN	3	$995,282	$0
Research for Development	Kigali	1	$928,400	$0
University of Minnesota	Minneapolis, MN	1	$894,702	$0
Information Management Services, Inc.	Calverton, MD	1	$887,000	$0
Pharmajet, Inc.	Golden, CO	1	$843,564	$0
University of Arkansas	Fayetteville, AR	1	$814,792	$0
Columbia University Health Sciences	New York, NY	1	$775,284	$0
Boston Medical Center	Boston, MA	1	$753,446	$0
Fred Hutchinson Cancer Research Center	Seattle, WA	2	$748,337	$0
H. Lee Moffitt Cancer CTR & Res Inst	Tampa, FL	1	$711,793	$0
Rutgers Biomedical and Health Sciences	Newark, NJ	1	$659,697	$0
Temple Univ of the Commonwealth	Philadelphia, PA	2	$602,259	$0
Saint Louis University	Saint Louis, MO	1	$566,887	$0
University of Cincinnati	Cincinnati, OH	1	$489,666	$0
Vaxsyna, Inc.	Franklin, NH	1	$437,203	$0
University of Kentucky	Lexington, KY	1	$427,380	$0
University of Massachusetts Boston	Dorchester, MA	1	$419,375	$0
Henry Ford Health + Michigan State University Health Sciences	East Lansing, MI	1	$401,343	$0
Phoenix Biosystem, Inc.	Pleasanton, CA	1	$382,034	$0
University of Texas at Austin	Austin, TX	1	$351,394	$0
Medical University of South Carolina	Charleston, SC	1	$343,172	$0
Meharry Medical College	Nashville, TN	1	$311,679	$0
University of Texas HLTH Sci CTR Houston	Houston, TX	2	$291,331	$0
University of Michigan at Ann Arbor	Ann Arbor, MI	1	$277,617	$0
University of Illinois at Urbana-Champaign	Urbana, IL	2	$203,078	$0
Northwestern University at Chicago	Chicago, IL	1	$191,700	$0
Yale University	New Haven, CT	1	$165,013	$0
University of Maryland Baltimore	Baltimore, MD	1	$140,740	$0
Stanford University	Stanford, CA	1	$131,166	$0
Novan, Inc.	Durham, NC	1	$126,371	$0
University of California-Irvine	Irvine, CA	1	$46,036	$0
Drexel University	Philadelphia, PA	1	$9,793	$0

Funding by fiscal year

Fiscal year	NIH awards	NIH amount	NSF amount
2025	35	$32,505,422	$0
2024	43	$35,711,155	$0
2023	55	$44,912,511	$0
2022	51	$41,742,550	$0
2021	43	$39,627,993	$0

Open federal funding opportunities

From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.

Open opportunity	Number	Agency	Listing	Closes	Award ceiling	Why it matches
NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed)	PA-24-194	NIH		May 7, 2027	Not listed	Notice number printed on 1 award here
Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed)	PA-24-185	NIH		May 7, 2027	Not listed	Notice number printed on 1 award here
NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)	PAR-27-089	NIH	93.393	November 2, 2026	Not listed	Same assistance listing 93.393 as 40 awards here
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)	PAR-25-095	NIH	93.393	November 6, 2026	$350,000	Same assistance listing 93.393 as 40 awards here
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)	PAR-25-096	NIH	93.393	November 17, 2026	$200,000	Same assistance listing 93.393 as 40 awards here
NCI Research Specialist Award for Core and Laboratory-based Scientists (R50 Clinical Trial Not Allowed)	PAR-27-088	NIH	93.393	November 20, 2026	Not listed	Same assistance listing 93.393 as 40 awards here
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)	PAR-24-214	NIH	93.393	January 7, 2027	$375,000	Same assistance listing 93.393 as 40 awards here
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)	PAR-25-069	NIH	93.393	January 7, 2027	Not listed	Same assistance listing 93.393 as 40 awards here
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)	PAR-25-070	NIH	93.393	January 7, 2027	Not listed	Same assistance listing 93.393 as 40 awards here
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)	PAR-25-081	NIH	93.393	January 7, 2027	$499,999	Same assistance listing 93.393 as 40 awards here
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)	PAR-25-167	NIH	93.393	January 7, 2027	Not listed	Same assistance listing 93.393 as 40 awards here
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)	RFA-NS-25-023	NIH	93.393	January 15, 2027	$350,000	Same assistance listing 93.393 as 40 awards here
Single Source: Coordinating Center (CC) for the Small Cell Lung Cancer (SCLC) Consortium (U24 Clinical Trial Not Allowed)	PAR-27-009	NIH	93.393	January 25, 2027	Not listed	Same assistance listing 93.393 as 40 awards here
Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed)	RFA-CA-26-010	NIH	93.393	January 25, 2027	Not listed	Same assistance listing 93.393 as 40 awards here
Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)	RFA-CA-28-013	NIH	93.393	February 9, 2027	$700,000	Same assistance listing 93.393 as 40 awards here
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)	PA-27-100	NIH	93.393	April 5, 2027	Not listed	Same assistance listing 93.393 as 40 awards here
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)	PA-27-102	NIH	93.393	April 5, 2027	Not listed	Same assistance listing 93.393 as 40 awards here
Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed)	PAR-28-057	NIH	93.393	May 25, 2027	$500,000	Same assistance listing 93.393 as 40 awards here
Implementation and Evaluation of Databases to Examine AIDS	RFA-AI-28-025	NIH	93.393	May 27, 2027	Not listed	Same assistance listing 93.393 as 40 awards here
Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)	PAR-25-210	NIH	93.393	June 2, 2027	Not listed	Same assistance listing 93.393 as 40 awards here

Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.